GB201506933D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB201506933D0
GB201506933D0 GBGB1506933.9A GB201506933A GB201506933D0 GB 201506933 D0 GB201506933 D0 GB 201506933D0 GB 201506933 A GB201506933 A GB 201506933A GB 201506933 D0 GB201506933 D0 GB 201506933D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1506933.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sentinel Oncology Ltd
Original Assignee
Sentinel Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentinel Oncology Ltd filed Critical Sentinel Oncology Ltd
Priority to GBGB1506933.9A priority Critical patent/GB201506933D0/en
Publication of GB201506933D0 publication Critical patent/GB201506933D0/en
Priority to PCT/EP2016/059091 priority patent/WO2016170163A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1506933.9A 2015-04-23 2015-04-23 Pharmaceutical compounds Ceased GB201506933D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1506933.9A GB201506933D0 (en) 2015-04-23 2015-04-23 Pharmaceutical compounds
PCT/EP2016/059091 WO2016170163A1 (en) 2015-04-23 2016-04-22 Substituted quinoxalines and benzotriazine p70s6 kinase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1506933.9A GB201506933D0 (en) 2015-04-23 2015-04-23 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB201506933D0 true GB201506933D0 (en) 2015-06-10

Family

ID=53488549

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1506933.9A Ceased GB201506933D0 (en) 2015-04-23 2015-04-23 Pharmaceutical compounds

Country Status (2)

Country Link
GB (1) GB201506933D0 (en)
WO (1) WO2016170163A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3848035A1 (en) 2015-12-10 2021-07-14 PTC Therapeutics, Inc. 1,4-disubstituted pyridazine compounds for treating huntington's disease
SG11201911615WA (en) 2017-06-05 2020-01-30 Ptc Therapeutics Inc Compounds for treating huntington's disease
CA3067591A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. Methods for treating huntington's disease
CA3067592A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. Methods for treating huntington's disease
WO2019191092A1 (en) 2018-03-27 2019-10-03 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
WO2020005882A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
JP7421507B2 (en) 2018-06-27 2024-01-24 ピーティーシー セラピューティクス， インコーポレイテッド Heterocyclic and heteroaryl compounds for treating Huntington's disease
IL264854A (en) 2019-02-14 2020-08-31 Bahat Anat Spt5 inhibitors and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1750727A2 (en) * 2004-04-23 2007-02-14 Exelixis, Inc. Kinase modulators and methods of use
GB0501999D0 (en) * 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
GB0908905D0 (en) * 2009-05-26 2009-07-01 Sentinel Oncology Ltd Pharmaceutical compounds
WO2014151147A1 (en) * 2013-03-15 2014-09-25 Intellikine, Llc Combination of kinase inhibitors and uses thereof

Also Published As

Publication number Publication date
WO2016170163A1 (en) 2016-10-27

Similar Documents

Publication Publication Date Title
IL266017A (en) Pharmaceutical compounds
IL258213A (en) Pharmaceutical compounds
GB201612092D0 (en) Pharmaceutical compounds
GB201511790D0 (en) Pharmaceutical compound
GB201617758D0 (en) Pharmaceutical compounds
GB201506658D0 (en) Pharmaceutical compounds
IL258246A (en) Pharmaceutical compounds
GB201504675D0 (en) Pharmaceutical compounds
GB201506660D0 (en) Pharmaceutical compounds
GB201519352D0 (en) Pharmaceutical compounds
ZA201900540B (en) Pharmaceutical compounds
HUE052107T2 (en) Pharmaceutical compounds
GB201612095D0 (en) Pharmaceutical compounds
GB201617454D0 (en) Pharmaceutical compounds
GB201506933D0 (en) Pharmaceutical compounds
GB201502567D0 (en) Pharmaceutical compounds
GB201516411D0 (en) Pharmaceutical compound
GB201617871D0 (en) Pharmaceutical compounds
SG11201708818VA (en) Pharmaceutical compound
ZA201904033B (en) Pharmaceutical compounds
HK1226067B (en) Pharmaceutical compounds
GB201614037D0 (en) Pharmaceutical compounds
SG11201708817XA (en) Pharmaceutical compound
GB201517451D0 (en) Pharmaceutical compounds
GB201602861D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)